申请人:H. Lundbeck A/S
公开号:US20030181445A1
公开(公告)日:2003-09-25
The invention provides novel compounds of the formula I below:
1
wherein the meaning of each substituent is defined in the application. The compounds are useful as inhibitors of the glycine transporter and useful in the treatment of diseases responsive to the inhibition of the glycine transporter. The invention provides a pharmaceutical composition comprising a compound of Formula I as defined above and the use of compounds as above for the manufacture of medicaments for treatment of diseases responsive to ligands of the glycine transporter.
本发明提供了以下式子I的新化合物:1其中每个取代基的含义在申请中定义。这些化合物可用作甘氨酸转运体的抑制剂,并且可用于治疗对甘氨酸转运体抑制剂敏感的疾病。本发明提供了一种药物组合物,包括上述式子I中定义的化合物,以及将上述化合物用于制造对甘氨酸转运体配体敏感的疾病的药物。